The most common side effects of zonisamide include: dizziness and lightheadedness fatigue and drowsiness language and speech difficulty metallic taste nausea Other possible side effects include: trouble sleeping lack of coordination loss of appetite and weight loss diarrhea double vision mood changes such as depression or irritability difficulty concentrating These symptoms may subside after your body adjusts to the medication
Metformin also reduces appetite, which leads to a modest amount of weight loss : about 8 pounds in seven months
Based on current clinical evidence, the rough ordering from largest to smallest weight-loss effect is: Tirzepatide highest average weight loss Semaglutide significant weight loss Tesamorelin moderate weight loss, primarily through visceral fat reduction AOD-9604 primarily body composition effects MOTS-c primarily metabolic and energy effects rather than pure weight reduction AOD-9604 and MOTS-c are generally not considered replacements for GLP-1 medications in patients seeking substantial weight reduction
Statistical tests supported this observation, and the trim and fill model did not identify any missing studies, further validating the robustness of the findings regarding FBS change
For the primary composite endpoint of myocardial infarction, stroke or all-cause mortality, benchmarking identified high agreement between the reference trials and their emulations for all individual endpoints except for all-cause mortality in SUSTAIN-6, informing subsequent analyses
Second, it shows your prescriber exactly what you have been doing, which helps them make better dose adjustment decisions